The composition and form of issue:
100 g of gel contain esqina 1 g and 5 g diethylaminoacetate in the box for 40 grams in a carton box 1 tube.
Prevents the activation of lysosomal enzymes that break down proteoglycan, reduces the fragility and permeability of capillaries, increases blood flow, eliminates venous stasis.
Description pharmacological action:
Escin, penetrating through the skin, prevents water retention in tissues and suppresses the formation of edema, inhibits inflammatory processes, eliminates local swelling. Diethylaminomethyl, has anti-inflammatory properties, which are enhanced by the escin, and causes analgesic effect.
Injury (bruises, sprain or torn ligaments, crushing of bones, hematoma, inflammation of the tendon sheath), pain syndromes associated with the pathology of the spine (pain in the back, lumbago, sciatica), inflammation in superficial veins (i.e. after injection or infusion), varicose veins.
Allergic reaction (skin).
Method of application and dose:
Topically applied to the affected areas, evenly distributing the gel (can be rubbed), one or more times a day.
Should not be applied to mucous membranes, damaged skin or areas of recently irradiated.
|The purpose of the medication||Anti-aggregants|